In Axis 4 (Table 1), miR-493-5p↓ ZIC2↑ MBNL2↑, MBNL2 is abnormally expressed in lung and breast cancer (Zhang J. et al., 2019), as well as hepatocellular carcinoma (Lee et al., 2016). Here, MBNL2 is linked to breast cancer.